Financhill
Sell
27

NBIS Quote, Financials, Valuation and Earnings

Last price:
$83.52
Seasonality move :
9.23%
Day range:
$82.00 - $89.00
52-week range:
$17.39 - $141.10
Dividend yield:
0%
P/E ratio:
81.96x
P/S ratio:
55.30x
P/B ratio:
4.37x
Volume:
31.9M
Avg. volume:
20M
1-year change:
361.8%
Market cap:
$21B
Revenue:
$117.5M
EPS (TTM):
-$1.53

Earnings Data

Next earnings date for NBIS
Feb 26
2026
Most recent earnings per share
-$0.48
Beat by $0.05
(Nov 11/2025)
Consensus Estimate
-$0.52
(Nov 11/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

NBIS Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/26/2026 Q4 $258.7M -- -- -$0.55 --
11/11/2025 Q3 $155.7M $146.1M -$0.48 -$0.52 $0.05
08/07/2025 Q2 $101.2M $105.1M -- -$0.42 --
05/20/2025 Q1 $57.7M $55.3M -$0.48 -$0.45 -$0.03
02/20/2025 Q4 $58.1M $37.9M -$0.58 -$0.39 -$0.19
10/31/2024 Q3 -- $43.3M -$0.47 -- --
08/01/2024 Q2 -- $24.9M $0.50 -- --
03/31/2024 Q1 -- $11.5M -- -- --
02/15/2024 Q4 -- $6.7M -$0.20 -- --
09/30/2023 Q3 -- $5M $0.23 -- --
06/30/2023 Q2 -- $4.7M $0.47 -- --
03/31/2023 Q1 -- $5.1M $0.16 -- --
12/31/2022 Q4 -- $2.6B $0.21 -- --
09/30/2022 Q3 -- $2.2B $1.93 -- --
06/30/2022 Q2 -- $1.8B $0.23 -- --
03/31/2022 Q1 -- $1.2B -$0.44 -- --
12/31/2021 Q4 -- $1.5B -$0.17 -- --
09/30/2021 Q3 -- $1.2B -$0.13 -- --
06/30/2021 Q2 -- $1.1B -$0.15 -- --
03/31/2021 Q1 -- $982.6M -$0.11 -- --
12/31/2020 Q4 -- $940.2M $0.01 -- --
09/30/2020 Q3 -- $790.5M $0.82 -- --
06/30/2020 Q2 -- $572.2M -$0.14 -- --
03/31/2020 Q1 -- $701.4M $0.26 -- --
12/31/2019 Q4 -- $811.3M $0.04 -- --
09/30/2019 Q3 -- $696.4M $0.23 -- --
06/30/2019 Q2 -- $641.2M $0.18 -- --
03/31/2019 Q1 -- $565.5M $0.16 -- --
12/31/2018 Q4 -- $583.4M $0.26 -- --
09/30/2018 Q3 -- $496.7M $0.22 -- --
06/30/2018 Q2 -- $478M $1.59 -- --
03/31/2018 Q1 -- $467.1M $0.12 -- --
12/31/2017 Q4 -- $476.8M $0.18 -- --
09/30/2017 Q3 -- $397.5M $0.05 -- --
06/30/2017 Q2 -- $386.2M $0.19 -- --
03/31/2017 Q1 -- $351.9M $0.04 -- --
12/31/2016 Q4 -- $350.8M $0.06 -- --
09/30/2016 Q3 -- $298.7M $0.12 -- --
06/30/2016 Q2 -- $274.1M $0.10 -- --
03/31/2016 Q1 -- $220.4M $0.04 -- --
12/31/2015 Q4 -- $273.8M $0.13 -- --

Nebius Group NV Earnings Questions

  • How Much did Nebius Group NV Generate in Revenue Last Quarter?

    Nebius Group NV reported $146.1M worth of top line sales in its most recent quarter.

  • Did Nebius Group NV Beat Earnings Last Quarter?

    Nebius Group NV announced earnings per share of -$0.48 which represents a beat of analyst forecast a -$0.52 per share.

  • Is Nebius Group NV Profitable?

    Nebius Group NV reported $4.2M that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Nebius Group NV EPS Next Year?

    Nebius Group NV's earnings are forecast to decrease from $0.51 per share to -$1.10 per share next year representing a decrease of -39.04%.

  • When is Nebius Group NV's Earnings Date?

    Nebius Group NV's next earnings date is February 26, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Robinhood Win Tokenization?
Will Robinhood Win Tokenization?

For many years, cryptocurrency enthusiasts have predicted a mass tokenization…

Does DraftKings Stock Have a Moat?
Does DraftKings Stock Have a Moat?

DraftKings (NASDAQ:DKNG) has been one of the largest beneficiaries of…

Is It Time To Buy Unity Stock?
Is It Time To Buy Unity Stock?

Unity Software (NYSE:U) is the business behind the popular Unity…

Stock Ideas

Sell
49
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Buy
62
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 37x

Alerts

Buy
88
CDTX alert for Nov 15

Cidara Therapeutics, Inc. [CDTX] is up 105.38% over the past day.

Buy
60
SRRK alert for Nov 15

Scholar Rock Holding Corp. [SRRK] is up 24.38% over the past day.

Buy
86
ZCSH alert for Nov 15

Grayscale Zcash Trust (ZEC) [ZCSH] is up 21.52% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock